Pill Connect secures £510k in Series A follow on funding led by Jonathan Milner to prepare for commercial launch.
The funding round was backed by Jonathan Milner, Catapult Ventures and Shallcross Partners to fund regulatory submissions and commercialisation.
Manchester medtech business that has developed a digital tracking device to monitor medication adherence in clinical trials. The reusable technology attaches to standard pill bottles to supply real-time dispensing data to pharmaceutical companies.
Manchester-based health technology firm Pill Connect has raised £510k in a Series A follow on funding round. The investment was backed by Jonathan Milner alongside Catapult Ventures and Shallcross Partners. The capital will be allocated towards finalising design, electronic and software development to secure regulatory clearance in Europe and the United States ahead of a commercial rollout.
The funding follows successful placebo trials of the electronic smart bottle cap system, which dispenses medication following app prompts and provides clinicians with detailed adherence records. The technology aims to tackle medication non-compliance issues that contribute to high healthcare costs and trial complications.
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
Pill Connect
Pill Connect builds digital tracking devices to monitor medication adherence in clinical trials.